A drug with the SMILES CCn1cc(C(=O)NCC2CCCO2)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 12.501\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCn1cc(C(=O)NCC2CCCO2)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21
CCn1cc(C(=O)NCC2CCCO2)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21
1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-N-(oxolan-2-ylmethyl)quinoline-3-carboxamide